Literature DB >> 11955558

From ugly fish to conquer death: J J R Macleod's fish insulin research, 1922-24.

James R Wright1.   

Abstract

Fish insulin research had a very short heyday. Throughout most of 1922, production of insulin from livestock was difficult, erratic, and expensive. Although fish insulin was easy to extract and seemed to be a brilliant and logical solution to the shortage of insulin, collection of fish islets was a logistical nightmare. By the end of 1922, a scientist at the pharmaceutical company Eli Lilly in Indianapolis, IN, USA had developed a way to concentrate and purify insulin by isoelectric precipitation. As a result of this breakthrough, the scales began to tip heavily in favour of livestock insulin. Nevertheless, research on commercial production of fish insulin continued for another 18 months but was finally abandoned.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955558     DOI: 10.1016/S0140-6736(02)08222-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

1.  Almost famous: E. Clark Noble, the common thread in the discovery of insulin and vinblastine.

Authors:  James R Wright
Journal:  CMAJ       Date:  2002-12-10       Impact factor: 8.262

Review 2.  Glucose metabolism in fish: a review.

Authors:  Sergio Polakof; Stéphane Panserat; José L Soengas; Thomas W Moon
Journal:  J Comp Physiol B       Date:  2012-04-05       Impact factor: 2.200

3.  What Was Known About Childhood Diabetes Mellitus Before the Discovery of Insulin?

Authors:  James R Wright
Journal:  Pediatr Dev Pathol       Date:  2021-09-13

4.  Ancestral genomic duplication of the insulin gene in tilapia: An analysis of possible implications for clinical islet xenotransplantation using donor islets from transgenic tilapia expressing a humanized insulin gene.

Authors:  Olga Hrytsenko; Bill Pohajdak; James R Wright
Journal:  Islets       Date:  2016-07-03       Impact factor: 2.694

Review 5.  A review of piscine islet xenotransplantation using wild-type tilapia donors and the production of transgenic tilapia expressing a "humanized" tilapia insulin.

Authors:  James R Wright; Hua Yang; Olga Hyrtsenko; Bao-You Xu; Weiming Yu; Bill Pohajdak
Journal:  Xenotransplantation       Date:  2014-07-05       Impact factor: 3.907

6.  Transgenic substitution with Greater Amberjack Seriola dumerili fish insulin 2 in NOD mice reduces beta cell immunogenicity.

Authors:  Kylie S Foo; Alicja A Skowronski; Danielle Baum; Rebuma Firdessa-Fite; Sebastian Thams; Linshan Shang; Rémi J Creusot; Charles A LeDuc; Dieter Egli; Rudolph L Leibel
Journal:  Sci Rep       Date:  2019-03-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.